Status:
COMPLETED
Composition for Treating Uterine Fibroid (SB-UF)
Lead Sponsor:
Trieu, Nguyen Thi, M.D.
Collaborating Sponsors:
TRAN MINH DUC, MD
Tran Minh Cam Tu, MD
Conditions:
Uterine Fibroids Affecting Pregnancy
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
Pregnenolone \& Pyridoxal Phosphate SB-UF for treating uterine fibroids in women's pregnancies to lose the size of fibroids and to dissolve fibroids. Uterine fibroids are a very common finding in wom...
Detailed Description
Uterine fibroids are a very common finding in women's pregnancy of reproductive age fibroids fast grow in the first trimester of pregnancy. Clinically has shown that: * Uterine fibroids are associat...
Eligibility Criteria
Inclusion
- Procedure to the treatment of fibroids in pregnancy and in women desiring future fertility.
Exclusion
- Subserosal fibroids may be pedunculated hanging from a stalk inside or outside the uterus.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04762316
Start Date
January 1 2019
End Date
February 1 2021
Last Update
May 18 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Saigon Biopharma LLC
Wilmington, Delaware, United States, 19801-6601
2
Saigon Biopharma Company Limited
Ho Chi Minh City, Vietnam, 700000